IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes
IceCure Medical Ltd., developer of minimally invasive cryoablation technology that destroys tumors by freezing them, announced that it has received a Notice of Allowance from the China National Intellectual Property Administration (CNIPA) for a new patent titled “Cryogen Flow Control.” The patent relates to IceCure’s next-generation XSense™ cryoablation system and...











